Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL759416 | 0.86 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16537916 | 0.85 | TSHR (0.49) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL17104402 | 0.84 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16537643 | 0.81 | TSHR (0.55) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16537898 | 0.81 | TSHR (0.51) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL1268912 | 0.80 | TSHR (0.46) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16537380 | 0.80 | TSHR (0.54) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL31290104 | 0.79 | TSHR (0.49) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL28352183 | 0.78 | TSHR (0.55) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16537377 | 0.77 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010026491-A2 | PROCEDURE TO REMOVE PIGMENTARY STAINS AND TATOOS ON THE SKIN BY A SOLID-STATE DYE LASER SYSTEM | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2010-03-11 | — | — | WO | claimed |
| US-8486428-B2 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-07-16 | — | — | US | disclosed |
| WO-2010026491-A2 | PROCEDURE TO REMOVE PIGMENTARY STAINS AND TATOOS ON THE SKIN BY A SOLID-STATE DYE LASER SYSTEM | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2010-03-11 | — | — | WO | disclosed |
| WO-2007126775-A2 | COMPOSITIONS AND METHODS FOR MAKING AND USING ACYCLIC N-HALAMINE-BASED BIOCIDAL POLYMERIC MATERIALS AND ARTICLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070224161-A1 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-09-27 | — | — | US | disclosed |
| US-7008990-B2 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-07 | — | — | US | disclosed |
| US-20030170306-A1 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070224161-A1 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | NAAA, NIT2, AADAC | TSHR 4421/4885THRB 4336/4885POLB 2103/4885 |
| US-20030170306-A1 | Use of polymeric reaction product | OXSR1, OGFR, CBR1 | TSHR 80/4885THRB 392/4885POLB 1020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.